Buy & Sell State Street SPDR S&P Biotech ETF (XBI) – State Street SPDR S&P Biotech ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Broad Market / FactorSector
- -8.57%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 21 daysTypical Hold Time
Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $82.93 and a high of $155.29, highlighting its annual price range. Over the past three months, State Street SPDR S&P Biotech ETF has recorded a drawdown of -8.57%, reflecting recent price volatility. On average, investors hold State Street SPDR S&P Biotech ETF for approximately 21 days, indicating typical investor behavior on the platform.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
Investors in Strategy Inc. may claim compensation over alleged misleading info in securities.
The Rosen Law Firm has announced an investigation into potential securities claims for shareholders of Strategy Inc. due to allegations that the company provided materially misleading business information. Investors who purchased Strategy securities ...

Ulta Beauty shares drop 20% YTD despite strong sales, creating a value buying opportunity.
Ulta Beauty's stock has fallen about 20% year-to-date, even though the company continues to show strong sales growth and gains in market share. This decline is largely due to investors rotating capital away from mega-cap tech stocks, which has left r...

iShares Emerging Markets ETF downgraded to hold after 39% surge amid high volatility and tech concentration
The iShares Core MSCI Emerging Markets ETF (IEMG) has been downgraded to hold following a 39% year-over-year gain, driven largely by South Korean and Taiwanese chip and memory stocks. Despite favorable valuations, the ETF faces elevated implied volat...
